Eli Lilly and Company (LLY)
Current ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 25,727,000 | 18,034,500 | 18,452,400 | 17,462,100 | 13,709,600 |
Total current liabilities | US$ in thousands | 27,293,200 | 17,138,200 | 15,052,700 | 12,481,600 | 11,775,200 |
Current ratio | 0.94 | 1.05 | 1.23 | 1.40 | 1.16 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $25,727,000K ÷ $27,293,200K
= 0.94
The current ratio of Lilly(Eli) & Co has exhibited a declining trend over the past five years, starting at 1.16 in 2019 and reaching 0.94 in 2023. This indicates that the company's current assets may not be sufficient to cover its current liabilities as effectively as in previous years. A current ratio below 1 suggests that the company may have difficulty meeting its short-term obligations with its current assets alone. It is important for investors and creditors to monitor this ratio closely as a decreasing trend may signal potential liquidity challenges for the company. Additional analysis of the components of current assets and current liabilities is recommended to gain a deeper understanding of the factors driving this trend in Lilly(Eli) & Co's current ratio.
Peer comparison
Dec 31, 2023